Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Search Results
4 results
Filters applied: . Clear all
Results are displayed in a computed author sort order.
The Results By Year timeline is not available.
Page 1
Eighteen-year survival after GD2-directed Chimeric Antigen Receptor-Modified Immune Effector Cell Treatment for Neuroblastoma.
Res Sq [Preprint]. 2024 Apr 11:rs.3.rs-4232549. doi: 10.21203/rs.3.rs-4232549/v1.
Res Sq. 2024.
PMID: 38659815
Free PMC article.
Preprint.
Long-term follow-up for the development of subsequent malignancies in patients treated with genetically modified IECs.
Steffin DHM, Muhsen IN, Hill LC, Ramos CA, Ahmed N, Hegde M, Wang T, Wu M, Gottschalk S, Whittle SB, Lulla PD, Mamonkin M, Omer B, Rouce RH, Heczey A, Metelitsa LS, Grilley BJ, Robertson C, Torrano V, Lapteva N, Gee AP, Rooney CM, Brenner MK, Heslop HE.
Steffin DHM, et al.
Blood. 2022 Jul 7;140(1):16-24. doi: 10.1182/blood.2022015728.
Blood. 2022.
PMID: 35325065
Free PMC article.
Item in Clipboard
Gene Therapy: Current Applications and Future Possibilities.
Steffin DHM, Hsieh EM, Rouce RH.
Steffin DHM, et al.
Adv Pediatr. 2019 Aug;66:37-54. doi: 10.1016/j.yapd.2019.04.001. Epub 2019 May 16.
Adv Pediatr. 2019.
PMID: 31230699
Review.
No abstract available.
Item in Clipboard
Epigenetic Inhibition Puts Target Antigen in the Crosshairs of CAR T Cells.
Steffin DHM, Heslop HE.
Steffin DHM, et al.
Mol Ther. 2019 May 8;27(5):900-901. doi: 10.1016/j.ymthe.2019.04.007. Epub 2019 Apr 18.
Mol Ther. 2019.
PMID: 31005599
Free PMC article.
No abstract available.
Item in Clipboard
Cite
Cite